NRAS and melanoma: We began our analysis using a simplified model in which we examined the behavior of INK4a-deficient and ARF-deficient mouse melanocytes infected with a retrovirus encoding oncogenic NRAS (NRASQ61K), which is mutated in 20% of human melanomas [20, 21].